Abstract
Cancer during pregnancy is a rare situation which demands a multidisciplinary care involving the surgical oncologist, the medical oncologist, the obstetrician and a host of other care givers. The care of the patient is planned in a way to optimize the health care delivery to the mother without compromising on the care of the fetus. When this is not possible priorities need to be established and harsh decisions taken on an individual basis. The treatment of the cancer does not change from the standard outside the limits described above and the objective should be to stay as close to the standard of care treatment as possible.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Pavlidis NA (2002) Coexistence of pregnancy and malignancy. Oncologist 7:279–287
Moran BJ, Yano H, Zahir NA, Farquharson M (2007) Conflicting priorities in surgical intervention for cancer in pregnancy. Lancet Oncol 8:536–544
Pentheroudakis G, Pavlidis N (2006) Cancer and pregnancy: Poena magna, not any more. Eur J Cancer 4:2126–2140
International Commission on Radiological Protection (2000) Pregnancy and medical irradiation. Ann ICRP 30:1–43
Nicklas A, Baker M (2000) Imaging strategies in pregnant cancer patients. Semin Oncol 27:623–632
Gentilini O, Cremonesi M, Trifiro G, et al. (2004) Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol 15:1348–1351
Mazze R, Kallen B (1989) Reproductive outcome after anesthesia and operation during pregnancy: A registry study of 5405 cases. Am J Obstet Gynecol 161: 1178–1185
Doll DC, Ringenberg QS, Yarbro JW (1988) Management of cancer during pregnancy. Arch Intern Med 148: 2058–2064
Van der Giessen PH (1997) Measurement of the peripheral dose for the tangential breast treatment technique with Co-60 gamma radiation and high-energy X-rays. Radiother Oncol 42:257–264
Buekers TE, Lallas TA (1998) Chemotherapy in pregnancy. Obs Gyn Clin North Am 25:323–329
Cardonick E, Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5:283–291
Zemlickis D, Lishner M, Degendorfer P, et al. (1992) Foetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 152:573–576
Doll DC, Ringenberg QS, Yarbro JW (1989) Antineoplastic agents and pregnancy. Semin Oncol 16:337–346
Germann N, Goffinet F, Goldwasser F (2004) Anthracyclines during pregnancy: embryo-foetal outcome in 160 patients. Ann Oncol 15:146–150
Aviles A, Neri N (2001) Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2:173–177
Brent RL (1999) Utilization of developmental basic science principles in the evaluation of reproductive risks from pre- and postconception environmental radiation exposures. Teratology 59:182–204
Woo JC, Taechin Y, Hurd TC (2003) Breast cancer in pregnancy. Arch Surg 138:91–98
Berkovitch M, Mazzota P, Greenberg R, et al. (2002) Metoclopramide for nausea and vomiting of pregnancy. A prospective multicentre international study. Am J Perinatol 19:311–316
Einasson A, Maltepe C, Navioz Y, et al. (2004) The safety of ondansentron for nausea and vomiting of pregnancy: A prospective comparative study. BJOG 111:240–243
Scott LL, Ramin SM, Richey M, et al. (1995) Erythropoietin use in pregnancy: two cases and a review of the literature. Am J Perinatol 12:22–24
Medlock ES, Kaplan DL, Cecchini M, et al. (1993) Granulocyte-colony stimulating factor crosses the placenta and stimulates foetal rat granulopoiesis. Blood 81:916–922
Dildy GA, Moise Jr KJ, Carpenter Jr RJ, et al. (1989) Maternal malignancy metastatic to the products of conception: a review. Obstet Gynecol Surv 44:535–540